参考文献:1. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119:3198鈥?06. CrossRef 2. Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol. 2012;59:2051鈥?. CrossRef 3. Foin N, Lee RD, Torii R, et al. Impact of stent strut design in metallic stents and biodegradable scaffolds. Int J Cardiol. 2014;177:800鈥?. CrossRef 4. Kolandaivelu K, Swaminathan R, Gibson WJ, et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation. 2011;123:1400鈥?. CrossRef 5. Suttorp MJ, Stella PR, Dens J, McKenzie JM, Park KS, Frambach P; on behalf of the SOLSTICE investigators. Ultra-thin Strut Cobalt Chromium Bare Metal Stent Usage in a Complex RealWorld (SOLSTICE Registry). Neth Heart J. 2015;23. Doi: 10.1007/s12471-014-0629-6 6. Yamaji K, Kimura T, Morimoto T, et al. Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation. Circ Cardiovasc Interv. 2010;3:468鈥?5. CrossRef